SocialPicks Monitor new  |    Stock Idea Community
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
Good Investment Ideas By People You Trust
SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.
Top_member_photos
Get free stock picks and email alerts daily
 
Are you a stock guru?

6 pts

Opinion on  Genentech Inc (DNA)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Buy Genentech (DNA) and get 15% compounded rate of return for 5 years.

Jun 12, 2007 01:43 PM UTC
Warren_buffett
Return Risk
-23.94% LOW
Associate

Fundamental Analysis  

The biotech sector hasn't been doing so well but Genentech (DNA), the world's second largest biotechnology company, should outperform over the long term. Genentech markets -Avastin for treating metastatic cancer of the colon or rectum and metastatic non-squamous non-small cell lung cancer, -Rituxan to treat B-cell non-Hodgkins lymphoma -Herceptin for treating node-positive breast cancer -





DNA:  This call was made on 06/12/07 @ $76.62
Rating:   Positive   $76.62 (06/12/07)
Gain/Loss:   -3.88% in 542 days


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 20.58 +45.12% 177
2 18.72 +43.19% 57
3 16.36 +17.64% 7
4 15.42 +40.59% 212
5 13.79 +16.71% 40


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Genentech Inc (DNA)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
83.0%
Top:
54.0%




Latest Picks by retirerichblog
Symbol SP Sentiment Rating Return Since
TEX Positive -74.52% 08/24/08
GRMN Positive -53.09% 08/24/08
BP Positive -24.02% 08/24/08
GS Positive -57.42% 08/24/08
ACH Positive -48.92% 08/24/08

View All >
   




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch